Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes
Top Cited Papers
- 1 March 2005
- journal article
- clinical trial
- Published by American Diabetes Association in Diabetes
- Vol. 54 (3) , 603-608
- https://doi.org/10.2337/diabetes.54.3.603
Abstract
To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used 1H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6-2H2]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were studied before and after weight stabilization on a moderately hypocaloric very-low-fat diet (3%). The diabetic patients were markedly insulin resistant in both liver and muscle compared with the lean control subjects. These changes were associated with marked increases in IHL (12.2 ± 3.4 vs. 0.6 ± 0.1%; P = 0.02) and IMCL (2.0 ± 0.3 vs. 1.2 ± 0.1%; P = 0.02) compared with the control subjects. A weight loss of only ∼8 kg resulted in normalization of fasting plasma glucose concentrations (8.8 ± 0.5 vs. 6.4 ± 0.3 mmol/l; P < 0.0005), rates of basal glucose production (193 ± 7 vs. 153 ± 10 mg/min; P < 0.0005), and the percentage suppression of hepatic glucose production during the clamp (29 ± 22 vs. 99 ± 3%; P = 0.003). These improvements in basal and insulin-stimulated hepatic glucose metabolism were associated with an 81 ± 4% reduction in IHL (P = 0.0009) but no significant change in insulin-stimulated peripheral glucose uptake or IMCL (2.0 ± 0.3 vs. 1.9 ± 0.3%; P = 0.21). In conclusion, these data support the hypothesis that moderate weight loss normalizes fasting hyperglycemia in patients with poorly controlled type 2 diabetes by mobilizing a relatively small pool of IHL, which reverses hepatic insulin resistance and normalizes rates of basal glucose production, independent of any changes in insulin-stimulated peripheral glucose metabolism.Keywords
This publication has 42 references indexed in Scilit:
- Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver DiseaseJournal of Biological Chemistry, 2004
- Cellular mechanisms of insulin resistanceJournal of Clinical Investigation, 2000
- Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feedingDiabetes, 1997
- Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humansDiabetes, 1997
- Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cellsEndocrinology, 1994
- Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.Journal of Clinical Investigation, 1992
- Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cellsEndocrinology, 1992
- Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog.Journal of Clinical Investigation, 1980
- The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.Journal of Clinical Investigation, 1976
- Studies of pancreatic alpha cell function in normal and diabetic subjectsJournal of Clinical Investigation, 1970